Monotherapy With Levetiracetam in Patients Suffering From Epilepsy.

Epilepsy, Tonic-clonic Clinical Trial

Official title:
A Multicenter, Open-label, Follow-up Trial Evaluating the Long-term Safety of Levetiracetam Individualized Dose From 1000 to 3000 mg/Day (Oral Tablets of 500 mg b.i.d.), Used as Monotherapy in Subjects (≥ 16 Years) Suffering From Epilepsy and Coming From the N01061 or the N01093 Trials.

Status Completed

Clinical Trial Summary

An open-label follow-up trial assessing the long term safety of levetiracetam as per adverse events reporting.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00150813
Study type	Interventional
Source	UCB Pharma
Contact
Status	Completed
Phase	Phase 3
Start date	August 10, 2005
Completion date	May 29, 2007

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04770337` - Pivotal-Safety and Therapeutic Measures of tDCS in Patients With Refractory Focal Epilepsy	N/A
Terminated	`NCT03831802` - Embrace and Quality of Life	N/A
Withdrawn	`NCT04282681` - XLTCS - Accelerometer Data Collection in an Epilepsy Monitoring Unit (EMU)
Completed	`NCT01439438` - Topiramate Bioequivalence Study Brazil - Fast	Phase 1
Completed	`NCT00150787` - Monotherapy With Levetiracetam or Carbamazepine in Patients Suffering From Epilepsy.	Phase 3
Completed	`NCT00231556` - A Study on Safety and Efficacy of Two Doses of Topiramate as Monotherapy in the Treatment of Newly Diagnosed or Recurrent Epilepsy	Phase 3
Completed	`NCT03446664` - Microburst Vagus Nerve Stimulator (VNS) Therapy Feasibility Study	N/A
Completed	`NCT00104416` - Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Primary Generalized Tonic-Clonic Seizures (PGTC) Seizures	Phase 3
Completed	`NCT00043901` - Treatment Of Primary Generalized Tonic-Clonic Seizures With An Investigational New Drug	Phase 4